Necuparanib

DB16251InvestigationalSmall molecule

Necuparanib is under investigation in clinical trial NCT01621243 (M402 in Combination With Nab-paclitaxel and Gemcitabine in Pancreatic Cancer).

Mechanism
Curator reviewed
Also known as
M-402 free acid · M402 free acid

Resolves to

Compound
UNIIULS0NT2D68CAS1415139-34-2
Targets
Q9Y251HPSE

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Necuparanib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In